HAYWARD, Calif., June 8, 2017 /PRNewswire/ -- Impax
Laboratories, Inc. (NASDAQ: IPXL) today announced that
the Company will present at the Goldman Sachs 38th
Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 13 at 2:40
p.m. Pacific Time (5:40 p.m. Eastern
Time).
Individuals may listen to the live or an archived presentation
made at the conference, which will be posted in the investor
relations section of the Company's web site at
www.impaxlabs.com. This presentation will be archived on the
Company's web site for 90 days.
About Impax Laboratories, Inc.
Impax Laboratories,
Inc. (Impax) is a specialty pharmaceutical company applying its
formulation expertise and drug delivery technology to the
development of controlled-release and specialty generics in
addition to the development of central nervous system disorder
branded products. Impax markets its generic products through its
Impax Generics division and markets its branded products through
the Impax Specialty Pharma division. Additionally, where
strategically appropriate, Impax develops marketing partnerships to
fully leverage its technology platform and pursues partnership
opportunities that offer alternative dosage form technologies, such
as injectables, nasal sprays, inhalers, patches, creams, and
ointments.
For more information, please visit the Company's Web site at:
www.impaxlabs.com.
Company
Contact:
Mark Donohue
Investor Relations and Corporate Communications
(215)
558-4526
www.impaxlabs.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/impax-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300471068.html
SOURCE Impax Laboratories, Inc.